Walczak H - Search Results

1

Enhancer Clusters Drive Type I Interferon-Induced TRAIL Overexpression in Cancer, and Its Intracellular Protein Accumulation Fails to Induce Apoptosis.

Di Benedetto C, Khan T, Serrano-Saenz S, Rodriguez-Lemus A, Klomsiri C, Beutel TM, Thach A, Walczak H, Betancur P. Di Benedetto C, et al. Among authors: walczak h. Cancers (Basel). 2023 Feb 3;15(3):967. doi: 10.3390/cancers15030967. Cancers (Basel). 2023. PMID: 36765925 Free PMC article.

2

TRAIL and other TRAIL receptor agonists as novel cancer therapeutics.

Falschlehner C, Ganten TM, Koschny R, Schaefer U, Walczak H. Falschlehner C, et al. Among authors: walczak h. Adv Exp Med Biol. 2009;647:195-206. doi: 10.1007/978-0-387-89520-8_14. Adv Exp Med Biol. 2009. PMID: 19760076 Review.

3

Getting TRAIL back on track for cancer therapy.

Lemke J, von Karstedt S, Zinngrebe J, Walczak H. Lemke J, et al. Among authors: walczak h. Cell Death Differ. 2014 Sep;21(9):1350-64. doi: 10.1038/cdd.2014.81. Epub 2014 Jun 20. Cell Death Differ. 2014. PMID: 24948009 Free PMC article. Review.

4

Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.

Förster A, Grotha SP, Seeger JM, Rabenhorst A, Gehring M, Raap U, Létard S, Dubreuil P, Kashkar H, Walczak H, Roers A, Hartmann K. Förster A, et al. Among authors: walczak h. Allergy. 2015 Jul;70(7):764-74. doi: 10.1111/all.12612. Epub 2015 Apr 16. Allergy. 2015. PMID: 25833810

5

The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2.

Hartwig T, Montinaro A, von Karstedt S, Sevko A, Surinova S, Chakravarthy A, Taraborrelli L, Draber P, Lafont E, Arce Vargas F, El-Bahrawy MA, Quezada SA, Walczak H. Hartwig T, et al. Among authors: walczak h. Mol Cell. 2017 Feb 16;65(4):730-742.e5. doi: 10.1016/j.molcel.2017.01.021. Mol Cell. 2017. PMID: 28212753 Free PMC article.

6

The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death.

Lafont E, Kantari-Mimoun C, Draber P, De Miguel D, Hartwig T, Reichert M, Kupka S, Shimizu Y, Taraborrelli L, Spit M, Sprick MR, Walczak H. Lafont E, et al. Among authors: walczak h. EMBO J. 2017 May 2;36(9):1147-1166. doi: 10.15252/embj.201695699. Epub 2017 Mar 3. EMBO J. 2017. PMID: 28258062 Free PMC article.

7

Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy.

von Karstedt S, Montinaro A, Walczak H. von Karstedt S, et al. Among authors: walczak h. Nat Rev Cancer. 2017 May 24;17(6):352-366. doi: 10.1038/nrc.2017.28. Nat Rev Cancer. 2017. PMID: 28536452 Free article. Review.

8

Paving TRAIL's Path with Ubiquitin.

Lafont E, Hartwig T, Walczak H. Lafont E, et al. Among authors: walczak h. Trends Biochem Sci. 2018 Jan;43(1):44-60. doi: 10.1016/j.tibs.2017.11.002. Epub 2017 Nov 28. Trends Biochem Sci. 2018. PMID: 29195774 Free article. Review.

9

An unexpected turn of fortune: targeting TRAIL-Rs in KRAS-driven cancer.

von Karstedt S, Walczak H. von Karstedt S, et al. Among authors: walczak h. Cell Death Discov. 2020 Mar 17;6:14. doi: 10.1038/s41420-020-0249-4. eCollection 2020. Cell Death Discov. 2020. PMID: 32194994 Free PMC article. Review.

10

TRAIL-receptor 2-a novel negative regulator of p53.

Willms A, Schupp H, Poelker M, Adawy A, Debus JF, Hartwig T, Krichel T, Fritsch J, Singh S, Walczak H, von Karstedt S, Schäfer H, Trauzold A. Willms A, et al. Among authors: walczak h. Cell Death Dis. 2021 Jul 31;12(8):757. doi: 10.1038/s41419-021-04048-1. Cell Death Dis. 2021. PMID: 34333527 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

225 results

Search Page